vTv Therapeutics upsizes ATM program to maximum authorized shares

vTv Therapeutics Inc.

Filed a prospectus supplement to increase shares offered under its at-the-market sales program to the full amount authorized.
The expanded ATM program is under the company's existing shelf registration statement on Form S-3.
Legal opinion from Dechert LLP on share legality was filed as part of the registration update.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.